Company testing goose antibody treatment for parvovirus

01/23/2014 | Minnesota Public Radio

Puppies and dogs not vaccinated against parvovirus face the greatest risk of contracting the deadly, highly contagious disease, according to the AVMA, which notes there is no pharmaceutical treatment available. But that could soon change, as Avianax has developed a goose antibody treatment. Veterinarian and Chief Science Officer Darin Meulebroeck says dogs who received the new therapy recovered in 24 hours, and although two treated dogs died, diagnosis was delayed in those cases. The USDA granted Avianax a permit to ship the product to some veterinarians for field testing.

View Full Article in:

Minnesota Public Radio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN